X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Glenmark Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs GLENMARK PHARMA - Comparison Results

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS GLENMARK PHARMA DR. DATSONS LABS/
GLENMARK PHARMA
 
P/E (TTM) x -10.9 14.2 - View Chart
P/BV x 0.2 3.8 4.3% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 DR. DATSONS LABS   GLENMARK PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
GLENMARK PHARMA
Mar-17
DR. DATSONS LABS/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs126993 12.6%   
Low Rs31729 4.2%   
Sales per share (Unadj.) Rs133.0325.5 40.9%  
Earnings per share (Unadj.) Rs0.239.3 0.4%  
Cash flow per share (Unadj.) Rs6.648.7 13.6%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs128.8159.2 80.9%  
Shares outstanding (eoy) m31.66282.17 11.2%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.62.6 22.2%   
Avg P/E ratio x516.121.9 2,355.0%  
P/CF ratio (eoy) x11.817.7 66.9%  
Price / Book Value ratio x0.65.4 11.2%  
Dividend payout %05.1 0.0%   
Avg Mkt Cap Rs m2,477242,991 1.0%   
No. of employees `000NA13.0 0.0%   
Total wages/salary Rs m5616,408 0.3%   
Avg. sales/employee Rs ThNM7,083.9-  
Avg. wages/employee Rs ThNM1,265.4-  
Avg. net profit/employee Rs ThNM855.1-  
INCOME DATA
Net Sales Rs m4,21191,857 4.6%  
Other income Rs m79374 21.1%   
Total revenues Rs m4,28992,230 4.7%   
Gross profit Rs m56920,367 2.8%  
Depreciation Rs m2042,644 7.7%   
Interest Rs m4302,373 18.1%   
Profit before tax Rs m1315,724 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-810 0.0%   
Tax Rs m63,827 0.2%   
Profit after tax Rs m511,088 0.0%  
Gross profit margin %13.522.2 60.9%  
Effective tax rate %48.024.3 197.4%   
Net profit margin %0.112.1 0.9%  
BALANCE SHEET DATA
Current assets Rs m6,85268,746 10.0%   
Current liabilities Rs m6,71127,027 24.8%   
Net working cap to sales %3.345.4 7.4%  
Current ratio x1.02.5 40.1%  
Inventory Days Days16185 189.2%  
Debtors Days Days31896 333.4%  
Net fixed assets Rs m3,67324,132 15.2%   
Share capital Rs m317282 112.2%   
"Free" reserves Rs m3,76144,643 8.4%   
Net worth Rs m4,07844,925 9.1%   
Long term debt Rs m1,67145,363 3.7%   
Total assets Rs m12,633117,639 10.7%  
Interest coverage x1.07.6 13.5%   
Debt to equity ratio x0.41.0 40.6%  
Sales to assets ratio x0.30.8 42.7%   
Return on assets %3.411.4 30.1%  
Return on equity %0.124.7 0.5%  
Return on capital %7.719.1 40.1%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96456,152 1.7%   
Fx outflow Rs m6078,084 7.5%   
Net fx Rs m35748,068 0.7%   
CASH FLOW
From Operations Rs m1,3456,574 20.5%  
From Investments Rs m-2,256-7,124 31.7%  
From Financial Activity Rs m-1,2005,432 -22.1%  
Net Cashflow Rs m-2,1111,992 -105.9%  

Share Holding

Indian Promoters % 4.5 48.3 9.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 6.9 -  
FIIs % 1.4 34.4 3.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 10.5 896.2%  
Shareholders   20,807 56,727 36.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CADILA HEALTHCARE  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON LTD  FULFORD INDIA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS